Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fecal microbiota transplantation live bacterial capsules
- Development stage
- Preclinical
- Lead developer
- Tianjin Anding Hospital
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Fecal microbiota transplantation (FMT) live bacterial capsules are an investigational oral live biotherapeutic product consisting of a diverse consortium of live commensal bacteria derived from the stool of healthy donors. The therapy is designed to restore a healthy gut microbiome composition and diversity, which is hypothesized to influence the gut-brain axis and alleviate symptoms of psychiatric disorders. In a clinical trial sponsored by Tianjin Anding Hospital (ChiCTR2500101022), these capsules are being evaluated for the treatment of depressive disorder and bipolar II disorder in adolescents, comparing their efficacy against transcranial magnetic stimulation (TMS) and placebo. The product aims to modulate systemic inflammation and neurotransmitter signaling through the restoration of intestinal microbial balance.
- Other names
- FMT capsulesoral fecal microbiota transplantation live bacterial capsules
02
Targets
GM (Gut microbiota community composition and function)
Beyond the preview
Go deeper on fecal microbiota transplantation live bacterial capsules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fecal microbiota transplantation live bacterial capsules.